Long-term safety and efficacy of tofogliflozin add-on to insulin in patients with type 2 diabetes: results from a 52-week, multicenter, randomized, double-blind, open-label extension, Phase 4 study in Japan (J-STEP/INS)
Terauchi, Yasuo, Tamura, Masahiro, Senda, Masayuki, Gunji, Ryoji, Kaku, KoheiLanguage:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13213
Date:
January, 2018
File:
PDF, 1.07 MB
english, 2018